Trials / Completed
CompletedNCT00115947
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function. Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terlipressin |
Timeline
- Start date
- 2004-12-01
- Completion
- 2006-01-01
- First posted
- 2005-06-27
- Last updated
- 2006-03-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00115947. Inclusion in this directory is not an endorsement.